Germline BRCA testing is moving from cancer risk assessment to a predictive biomarker for targeting cancer therapeutics
Crossref DOI link: https://doi.org/10.1007/s12094-015-1470-0
Published Online: 2016-01-07
Published Print: 2016-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Moreno, L.
Linossi, C.
Esteban, I.
Gadea, N.
Carrasco, E.
Bonache, S.
Gutiérrez-Enríquez, S.
Cruz, C.
Díez, O.
Balmaña, J.
Text and Data Mining valid from 2016-01-07